Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
130M
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+1.73M
-
Total reported value, excl. options
-
$4.02B
-
Value change
-
+$21.8M
-
Put/Call ratio
-
0.57
-
Number of buys
-
113
-
Number of sells
-
-158
-
Price
-
$34.12
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q4 2021
371 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q4 2021.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 130M outstanding shares and own 90.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (19.3M shares), VANGUARD GROUP INC (12.9M shares), WELLINGTON MANAGEMENT GROUP LLP (11.1M shares), Artisan Partners Limited Partnership (7.73M shares), JANUS HENDERSON GROUP PLC (4.39M shares), STATE STREET CORP (3.81M shares), Invesco Ltd. (3.75M shares), BROWN ADVISORY INC (3.72M shares), AMERIPRISE FINANCIAL INC (2.33M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.05M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.